logo
Plus   Neg
Share
Email

PZ Cussons Appoints Avon Products' Jonathan Myers As CEO, Effective May 1

Consumer products group PZ Cussons Plc. (PZC.L) announced Thursday the appointment of Jonathan Myers as Chief Executive Officer with effect from May 1.

Myers joins from Avon Products Inc, where he has been Chief Operating Officer since 2017. He spent the first 21 years of his career at Procter & Gamble.

The company noted that Caroline Silver will continue to serve as Executive Chair until Myers joins the business.

The Company also announced the appointment of Jeremy Townsend as a Non-executive Director with effect from April 1. Jeremy is currently Chief Financial Officer of Rentokil Initial plc.

Jez Maiden, who has served the Board as a Non-executive Director since 2016, has advised the Company of his intention to step down on May 31. He will be succeeded as Chair of the Audit & Risk Committee by Jeremy Townsend.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Moderna said Tuesday that it has reached an agreement with the U.S. to initially supply 100 million doses of its experimental vaccine for COVID-19, mRNA-1273. The U.S. government has awarded up to $1.525 billion for the vaccine. Las Vegas, Nevada-based Mr. Wok Foods has recalled about 200,000 pounds of meat and poultry products for misbranding and undeclared allergens, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS said. The recalled products may contain known allergens such as milk, wheat, soy, peanuts, or oysters. They may also contain MSG, sesame products, or sulfites. The U.S. Food and Drug Administration approved the first oral drug to treat patients two months of age and older with spinal muscular atrophy (SMA) that can be taken at home. Roche subsidiary Genentech's Evrysdi (risdiplam) is also the second FDA-approved drug to treat this rare and often fatal genetic disease affecting muscle strength and movement.
Follow RTT